[1] Rössle M. TIPS: 25 years later[J]. J Hepatol, 2013,59(5):1081-1093. DOI: 10.1016/j.jhep.2013.06.014.
[2] 韩斌,李海玲,植剑芳,等.瞬时弹性成像技术在乙肝肝硬化门静脉高压患者中的应用[J].国际医药卫生导报,2021,27(22):3446-3449.DOI:10.3760/cma.j.issn.1007-1245.2021.22.003.
[3] Riggio O, Nardelli S, Moscucci F, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Clin Liver Dis, 2012,16(1):133-146. DOI: 10.1016/j.cld.2011.12.008.
[4] Riggio O, Masini A, Efrati C, et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study[J]. J Hepatol, 2005,42(5):674-679. DOI: 10.1016/j.jhep.2004.12.028.
[5] Yao J, Zuo L, An G, et al. Risk factors for hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma and portal hypertension[J]. J Gastrointestin Liver Dis, 2015,24(3):301-307. DOI: 10.15403/jgld.2014.1121.243.yao..
[6] He F, Dai S, Xiao Z, et al. Pathological predictors of shunt stenosis and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Biomed Res Int, 2016,2016:3681731. DOI: 10.1155/2016/3681731.
[7] Berlioux P, Robic MA, Poirson H, et al. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests[J]. Hepatology, 2014,59(2):622-629. DOI: 10.1002/hep.26684.
[8] Nardelli S, Gioia S, Pasquale C, et al. Cognitive impairment predicts the occurrence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt[J]. Am J Gastroenterol, 2016,111(4):523-528. DOI: 10.1038/ajg.2016.29.
[9] Teng D, Zuo H, Liu L, et al. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment[J]. Virol J, 2018,15(1):151. DOI: 10.1186/s12985-018-1067-7.
[10] Masson S, Mardini HA, Rose JD, et al. Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt insertion: a decade of experience[J]. QJM, 2008,101(6):493-501. DOI: 10.1093/qjmed/hcn037.
[11] Casadaban LC, Parvinian A, Minocha J, et al. Clearing the confusion over hepatic encephalopathy after tips creation: incidence, prognostic factors, and clinical outcomes[J]. Dig Dis Sci, 2015,60(4):1059-1066. DOI: 10.1007/s10620-014-3391-0.
[12] Nardelli S, Lattanzi B, Torrisi S, et al. Sarcopenia is risk factor for development of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement[J]. Clin Gastroenterol Hepatol, 2017,15(6):934-936. DOI: 10.1016/j.cgh.2016.10.028.
[13] Rowley MW, Choi M, Chen S, et al. Race and gradient difference are associated with increased risk of hepatic encephalopathy hospital admission after transjugular intrahepatic portosystemic shunt placement[J]. J Clin Exp Hepatol, 2018,8(3):256-261. DOI: 10.1016/j.jceh.2017. 12.003.
[14] 罗薛峰.介入治疗胃静脉曲张:过去、现在和将来[J/CD].中华介入放射学电子杂志,2019,7(2):95-100.DOI:10.3877/cma.j.issn.2095-5782.2019.02.002.
[15] Rösch J, Uchida BT, Putnam JS, et al. Experimental intrahepatic portacaval anastomosis: use of expandable Gianturco stents[J]. Radiology, 1987,162(2):481-485. DOI: 10.1148/radiology.162.2.3797662.
[16] LaBerge JM, Ring EJ, Gordon RL. Percutaneous intrahepatic portosystemic shunt created via a femoral vein approach[J]. Radiology, 1991,181(3):679-681. DOI: 10.1148/radiology.181.3.1947081.
[17] Ring EJ, Lake JR, Roberts JP, et al. Using transjugular intrahepatic portosystemic shunts to control variceal bleeding before liver transplantation[J]. Ann Intern Med, 1992,116(4):304-309. DOI: 10.7326/0003-4819-116-4-304.
[18] LaBerge JM, Ring EJ, Lake JR, et al. Transjugular intrahepatic portosystemic shunts: preliminary results in 25 patients[J]. J Vasc Surg, 1992,16(2):258-267. DOI: 10.1067/mva.1992.37161.
[19] LaBerge JM, Ring EJ, Gordon RL, et al. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients[J]. Radiology, 1993,187(2):413-420. DOI: 10.1148/radiology.187.2.8475283.
[20] Sahagun G, Benner KG, Saxon R, et al. Outcome of 100 patients after transjugular intrahepatic portosystemic shunt for variceal hemorrhage[J]. Am J Gastroenterol, 1997,92(9):1444-1452.
[21] 齐瑞兆,史宪杰,李志伟,等.门静脉高压症上消化道出血不同指南诊治共识外科部分的比较分析[J].临床外科杂志,2019,27(1):62-66.
[22] de Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015,63(3):743-752. DOI: 10.1016/j.jhep.2015.05.022.
[23] Garcia-Tsao G, Abraldes JG, Berzigotti A, et al. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017,65(1):310-335. DOI: 10.1002/hep.28906.
[24] Jalan R, Hayes PC. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology[J]. Gut, 2000,46 Suppl 3-4(Suppl 3):III1-III15. DOI: 10.1136/gut.46.suppl_3.iii1.
[25] Reiberger T, Püspök A, Schoder M, et al. Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III)[J]. Wien Klin Wochenschr, 2017,129 Suppl 3:135-158. DOI: 10.1007/s00508-017-1262-3.
[26] Bittencourt PL, Strauss E, Farias AQ, et al. Variceal bleeding: update of recommendations from the brazilian association of hepatology[J]. Arq Gastroenterol, 2017,54(4):349-355. DOI: 10.1590/S0004-2803. 201700000-79.
[27] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会内镜学分会.肝硬化门静脉高压食管胃静脉曲张出血的防治指南[J].临床肝胆病杂志,2016,32(2):203-219.DOI:10.3969/j.issn.1001-5256.2016.02.002.
[28] 中华医学会外科学分会门静脉高压症学组.肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2015)[J].中国实用外科杂志,2015,35(10):1086-1090.DOI:10.7504/CJPS.ISSN1005-2208.2015.10.16.
[29] 中国医师协会介入医师分会.中国门静脉高压经颈静脉肝内门体分流术临床实践指南(2019年版)[J].临床肝胆病杂志,2019,35(12):2694-2699.DOI:10.3969/j.issn.1001- 5256. 2019.12.010.
[30] Ishikawa T, Sasaki R, Nishimura T, et al. Comparison of patients with hepatic encephalopathy and those with gastric varices before and after balloon-occluded retrograde transvenous obliteration[J]. Hepatol Res, 2018,48(12):1020-1030. DOI: 10.1111/hepr.13199.
|